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1 0 .  C O N C L U S I O N S  A N D  S U G G E S T I O N S  F O R  F U T U R E
RESEARCH
\X4een we started our studies, only a hmrted amourit of research had been
conducted in the field of hlpochondriasis. I(ellner and Barsky, both among
a group of colleagues, were the rnain authors in this area. However, the last
couple of years have shown a growing interest in hypochondriasis and the
other somatoforrn disorders.
The results of the treatment studies in the previous chapters and of studies
by other researchers (see chapter 3), should put an end to the pessimisuc
vieu' on tl-re prognosis of hlpochondriasis. At thrs moment, considerable
information is ar.ailable about the essential aspects of the hypochondnacal
svndrome and about strategies to treat this disorder effecuvely. In thts
chapter the main results of the previor-rs chapters will be summarized,
follorved by some general conclusions and irnphcauons for future research.
ASSESSMENT AND DIAGNOSIS
As r.vas shown in rhe previous chapters, the group of hlpochondnacal
patients is diverse and hr.pochondriasis shorvs a considerable ovedap u.'rth
other mental disorders. Besides, different authors have interpreted the
diagrosis hlpochondriasis differendy, and some have used different
dragnostrcal terms to describe the same disorder, leading to diagnosncal
confusion and r.rnreliabihn'. Even rvhen evervone would use the same
classification criteda, for example the DSNI,IV, there strll would be
diagnosucal problerns and problems in the drfferentral diagnostrcs, as was
described rn chapter 2. For that reasofl, ftirther improvements on
diagnostrcal instruments and sharpenrng of the criteria is necessary. The
research on illness attltude scales, as described in chapter 4, is a first step,
but further research rn this area is desirable. The construction of a structured
inten'ierv for somatoform disordets (e.g., Barskv et al., 1,992) is an example
of A cler step forward. Further, differentiation in subrypes of
hypochondriasis, as has been done rvith - for instance - obsessive
compulsive disotder, can be useful. A related theme is the
multidimensionahry of hypochondriasis; the discussion about this topic has
hardly started (Warwick & Salkovskis, 1990; Schmidt, 1994).
EFFECTIVE TREATMENTS
Several controlled studies on the treatment of hlpochondriasis a(e now
available, and they allow more definite conclusions about effective
interventions for the treatment of hypochondriacal complaints. T'hey
concenttated on the effecdveness of behavioural and cognitive interventions
and cleady showed that behavioural intewentions such as exposure in vivo
and response prevention are effective flVanr,rck & Marks, 1988; Visser &
Bouman, 1992; Bouman & Visser, 1.998; Visser & Bouman, submrtted).
Further, behavioural stress management (consisung of idenufication of
stressors, appJied relaxation procedures, stress management procedures)
showed to be effective in the long term (Clark et al., 1998). Cognitive
therapy - wrth or without behavioural experiments - also appeared to be an
effecrive treatment for hlpochondriasis in several studies flWarwck et al.,
1996; Bouman & Visser, 1998; Clark et al., 1998; Visser & Bouman,
submitted).
In those studies, in which different treatments were compared, all the
treatments shor.ved to be equally effective (at least in the long term, ot with
marylnal differences). All of them included a number of different elements.
Some of these belong to the so-called common factors, such as ^
relationship with a ftind and empathic) therapist, the presentation of a
credible rationale, and the presence of a context that is considered to be
therapeutic (fot a revierv see Lambert & Bergin, 1994). Others elements are
more specific, such as certain behavioural or cognitive procedures. So,
although effective treatments ate available, we do not know 1et which
elements are essential in the treatment.
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Research with more differentiated therapeutic interwentions ('dismantling
strategres') and 'placebo therapies' could shed some light on this matter.
Reports about unsuccessful treatments or interventions would also be
helpful, but, unfortunately, these are scarce.
PROGNOSIS AND LONG TERM EFFECTS.
In chapter B the prognostic value of sevetal variables was evaluated and
appeared to be Limited. The best predictors for long term effects were the
results that patients gained during therapy. In general, the possibrhty to
predict the effects of a particular treatment has been showed to be very
Lirnited (Steketee & Chambless,l,992). Several explanations can be proposed
for this finding. First is that the researchers selected the wrong variabies;
however, i.t is rather improbable that they all selected the wrong variables. A
more appealing explanation is that so many variables play a role in treatment
effect that each variable on its own has only a very limited influence on
treafl:rlent outcome. A third explanation is that treatment outcome is so
indrr,'rdually, idiosyncratically determrned that analyses on groups of patients
conceal such individual tesults. Analyses on the process of indrvidual
treatments might grve more indications about prognosis of specific
interventions
PROCESS /  THERAPEUTIC BOND
OrLrnsky et al. (1994) describe in an overview of process and outcome in
psychotherapy, that beside the therapeutic operations the therapeutic
contract and thetapeutic bond are essential for treatment outcome. The
importance of a good treatment contract, wrth a clear agreement about the
focus of the treatment, was emphasized in chapter 5. Such contracts were
used in our pilot studies and in the multi-centre study, but their specific
contribution to the final outcome temained unclear. It would be interesting
to compare treatments wrth and without such clear contracts ot, on the
other hand, two treatments that share such contract, but differ in the
number of treatment sessions aftelwards. After all, in our multi centre study
a number of patients were much improved after a very Lirnited number of
sessions (some of them were considered drop-outsl). A treatment protocol
with the possibrjrgv of a hmited number of sessions for specific patients
would be an option. It is unclear rvhich patients rvould benefit from such a
hmrted protocol. Patient variables should be idenufied, iike motivation,
psvchologrcal functioning and r'"rlhngness to invest in the treatment could
play a role.
A variable in the therapeutic bond that may be especially important rn the
treafinent of hypochondriacal patients is the ability of the therapist to
motivate patients to go on uth the proposed strateg)', itr stead of terurning
to a medical doctor. In our srudies, such motivational techniques rvere
trained and used in the sessions, not onll '  21 the beginning of treatment bllt
during the whoie therap),, but their importance for the final result is unclear.
All treatment sessions in our str,rdies u'ere recotded on tape and rvere used in
the supervision sessions in order to enhance the tteatment integrin'. These
tapes have not been anal-vsed yet, but they wili glve more information on the
process in the indtvidual treatments and the importance of tl-re variables
mentioned above.
DROP.OUTS /  NON IMPROVERS
In chapter 9 s'e committed a modest attempt to get more clariq'about the
phenomenon of patients rvho drop out of therapr'. 'fhis is a uncr-rltivated
area in the field of ps,vchotherapv. Norvadavs it is popuiar to hanclle the
problem of drop-outs by condr,rcting 'intent-to treat' analyses, rvhich implies
that estimatjons are used for the data of the patients who dropped out,
based on extrapolation of the results of the patients rvho stat.ed in therapv.
These statistical procedures have therr l-rmrtatrons, because they are based on
assumptions about the drop-outs s'hich have got no empirical support vet.
We do not know whether drop-outs - in comparison with patients rvho
finish the ffeatment - 1. form another npe of patients, e.g. are less or more
depressive or have less or more clelusions 2. are conparable u,rth the
'average' patient, or 3. are cornparablc rrrth paucnts with the same pre-
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treatment scores. Besides the limrtations of the statistical estimations, there
is dre differentiation in the selection criteria of patients entering a treatment
studv. The inclusion criteria define the rintent-to-treatr sample. The
expectation is that the more strict the inclusion criteria are, the lesser drop-
outs well be in the study. For example, both the Warwick et al. (1996) and
the Clark et al. (1998) studies had extreme low drop-out rates, rvhich may be
caused bv the fact that both srudies used ven' strict selection criteria, such as
a strong motivation for treatment and a current conviction of being
suffering from a serious illness. Horvever, the use of such strict inclusion
cdteria Lirnits the generalizability of the results to other than universiry
clinics wrth stricdv selected pati.ents.
In short: there is a lack of information about charactedstics of drop-outs. In
chapter B rve tried to create a profile of the patients who risk to drop out of
treatment. The motivation of the patients to stop the treatment prematurely
is largely based on subjecuve answers of the patients, with a number of
patients giving no explanation and the question u'hether poLite, friendlv
patients gave the real reason for stopping the treatment. An rndependent
and stmctllred interview with patients dropping out wouid improve the
reliabfity of the data. The importance of research on drop-outs, not only for
hlpochondriasis but the whole field of psychotherapy, is recognised by
more researchers and we expect more studies on drop-outs in the years
comrng.
Besides the patients rvho dropped out of treatment, there rvere patients rvho
drd not profit from the treatments, or even got worse. Just as it is not clear
whrch factors lead to a positive result, the same applies to the factors that
lead to a negative outcome and to the question whether both kinds of
factors are each others colrnterpart or not. They can include patient
characteristics, either or not in combinauon with the offered treatment,
therapist characteristics, the therapeutic bond, and other factors that are not
under control of a therapist, such as important changes in patients' lives.
Further improvement of the treatment interventions is one of the necessary
steps as Iong as there is a group patients who do not improve. F-urther
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research wrth other interventions is needed, such as attention training, self
help groups and interventions from other therapeuric orientations.
PRIMARY CARE
In chapter 3 it was alreadv mentioned that most studies have been
conducted in secondary health care, whereas most hlpochondriacal patients
are first 'recognised' in a primarl- care setting, mainly by the general
practitioner. The need for studies directed at ^n eadier assessment
(fopllowoing signals like frequent doctor visits, more referrals and qtucker
irritation on the doctors' side) and more effective management (tncluding
hmrted interventions) in primary care is large.
Smrth et al (1986) conducted a promrsing study on the management of
somatization disorder in prrmaq' care and found promrsing results with
srmple interventions. A comparabie study should be conducted in the field
of hlpochondriasis.
The general practitioner is often confronted with hJpochondriacal patienrs
who do not want an,v psychotherapeuuc help but further medical
investigations and referrals to somatic medical specialists. Goldberg et al.
(1989) formulated a model to help doctors to change the discussion wrth
patients, away f1611 the bodiy preoccupation and more directed to the
overconcern. This model couid be adjusted to hlrpochondriacal patients and
evaluated in a study.
PHARMACOLOGICAL TREATMENT
It is surprising that so litde research has been conducted in the field of
pharmacologrcal treatment of hlpochondriasrs. A couple of controlled
studies are in preparation at the moment, and the uncontrolled srudies
conducted until rrow are interesung. There ^te indications that
pharmacologrcal treatments can be effective wrth hlpochondriasis (ut
described in chapter 2). On the other hand, Fallon et al. (1996) found a large
effect in the placebo condition. The last finding suggested that the
expectations of the patients influence the complaints. One couid imagne
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that 'active' placebo's (with side-effects) could even have ^ gte^tet possible
effect (if the patients continue to take their medicatron). However, this
supposed suggesubility seems contradictory with the results by Heanen et al.
(1998), who found that hlpochondriacs were less suggestible than normals.
Horvever, their experiment concentrated on suggesubrJrW to external sumuli.
The researchets suggested that hlpochondriacal suggestibility may be more
directed to intetnal bodily processes than to external stimuli. A higher
suggesubihry for internal processes could vzell explain the placebo effect. In
all, it is obvious drat more experiments and research should be conducted
on suggestibrlity and placebo processes. In srudies on pharmacologrcal
treatments of patients with hlpochondriasis, researchers are confronted with
specific problems that are related to the hypochondriacal atutude. Many
hlpochondriacal patients are preoccupied with an optimal, healthy way of
Iiving and consider medication as unhealthy. Therefore, some pafients refuse
to take an,v medication. Besides refusal, there ^re some reports of
problematic apphcation of psychoph ^ rrnaca wrth hypochondriacs (Ilarsky,
1996; I(ellne41992). Recendy, in most of the trials tricvclic-antidepressants
or seiective serotonin re-uptake inhibitors (SSRI) were used. This type of
medication has side-effects, especiall), in thc begrnning of usage. These side
effects may have caused that the hlpochondriacal preoccupation was
increased, because patients interpreted these sensations as evidence for the
feared disease, discontinued the medicauon and dropped out. Research on
the question, whether the irrational interpretations of hlpochondriacal
patients lead to refusing of discontinuing medicatron, is certainly needed.
FUTURE RESEARCH
In tire prer.ious cl-rapters and the paragraphs above several suggestions for
future research were made. Some additrons are given in this last paragraph.
The aetrology of hlpochondriasis is still unclear. Some indications can be
found in the literafure and in clinical impressions. Our impressions during
our treatments were that factors such as life events (especially related to
serious i l lnesses) and grief about a deceased relative can plar, an important
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role in the aetiologv of hlr:ochondriasis. As indicated in chaptet 7, rearing
practices might also be related to the development of hypochondriacal
complaints. There is cleady ^  great need for a long-term prognostic study on
the aetrology and course of hlpochondriasis
In the historical overview (chapter 2) it was described that the meaning of
hypochondnasis has ciranged through the ages and that some aspects have
drsappeared in the course of the years. One example of the lattet is the
preoccupation of having a mental disorder (for instance Ladee, 1.966;
Itenyon, 1965), which fot long time was considered to be a manifestation of
hypochondriasis. In the last decades no reports have been written about
patients who suffer from this complaint. It can be questioned rvhether these
patients either have disappeared or srmpl.v get another classification
nowadavs. The same applies to the psvchotic tlpe that was included in the
diagnosis hlpochondriasis in eadier rimes. Nowadays, this disorder is
classified as a delusional disorder, somatic qpe. Recendy, the first srudies
were pub)ished on cognitive behavioural treatments for this psychotrc tlpe
(Garery et a1.,1994; Drury et aL,1,996; I{uipers et aI., t997), but a controlled
srudy in this area has not been conducted yet.
Dunng our sfildies we were also confronted wrth a hypochondriacal
preoccupation that was difficult to classi$, in the DSM-IV: the
preoccupation that someone close to the pauent was suffering from a
serious disease. V/e called this 'hlpochondriasis by proxy', but could not find
anything on this phenomenon in the literature. It would be interesting to
study whether effective treatments in hlrrochondriasis - in a slighdy
modified form - are effective in the treatment of this 'hypochondriasis b;,
proxv'.
Hlpochondriacal pauents have an overwhelming fear of having a higher risk
dpng from a serious disease. As far as we know there are no data available
whether in the long term there is a different risk of d)'ing from a senous
disease in the populauon of hlpochondriacs. Srudies with the converslon
disorder showed shocking high percentages of patients in the long term
suffering from a neurological disease (see Rooijmans, 1986; Weintraub,
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1983). We hope that our c[nical impression is justified that these high
percentages will not be found for hypochondriacal patients.
We hke to finish wrth an aspect we already mentioned in the introduction.
Hlpochondriacal patients vu'ere and are not very popular (see Sharpe et al.,
1994). We have been working wrth these patients now for many years, and
have been suffedng frorn tire same feelings of irritation or helplessness that
have been reported in the literarure. However, it must be emphasized that
many of such feeiirrgs are the result of irrational cognitions about these
patients and about the prognosis of their treatments. Although patients wrth
this disorder can have irritatrng behar.iours, their behavrou{ stems from a
strong and intense fear of suffering from a serious and fatal drsease.
Regarding the fact that some effective treatments are availabie, it is the task
of the theraprst to react to this behaviour adequately and to shorv
consideration and empathy wrth this fear. Only in this way therapists will
not be overwhelmed by feel-ings of irritation or hopelessness and patients
will be able to benefit from the treatment.
